MiMedx Group, Inc. (MDXG) stock
MDXGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 12/3040% below fair value
$3.18+0.00 (0.00%)
Close on Nov 17, 2026Market cap $464.04MP/E –Yield –
MiMedx operating margin
Operating margin is operating income as a percentage of revenue.
MiMedx's operating margin for the twelve months ending Sep 30, 2026 was -8.3%. For fiscal 2025 it was 15.3%, against 16.9% the year before. The highest annual figure on record is 16.9% in fiscal 2024.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 15.3% | −1.6 |
| FY2024 | Dec 31, 2024 | 16.9% | +5.3 |
| FY2023 | Dec 31, 2023 | 11.5% | +17.0 |
| FY2022 | Dec 31, 2022 | -5.5% | −2.6 |
| FY2021 | Dec 31, 2021 | -2.9% | +15.4 |
| FY2020 | Dec 31, 2020 | -18.3% | −11.2 |
| FY2019 | Dec 31, 2019 | -7.1% | −6.0 |
| FY2018 | Dec 31, 2018 | -1.1% | −15.5 |
| FY2017 | Dec 31, 2017 | 14.4% | +14.0 |
| FY2016 | Dec 31, 2016 | 0.4% | −12.6 |
| FY2015 | Dec 31, 2015 | 13.0% | +7.0 |
| FY2014 | Dec 31, 2014 | 6.0% | +10.5 |
| FY2013 | Dec 31, 2013 | -4.5% | +15.3 |
| FY2012 | Dec 31, 2012 | -19.8% | +106.0 |
| FY2011 | Dec 31, 2011 | -125.8% | +1209.4 |
| FY2010 | Dec 31, 2010 | -1335.2% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -18.8% | −38.3 |
| Q2 FY2026 | Jun 30, 2026 | -28.7% | −41.2 |
| Q1 FY2026 | Mar 31, 2026 | -27.2% | −36.6 |
| Q4 FY2025 | Dec 31, 2025 | 17.8% | +5.9 |
| Q3 FY2025 | Sep 30, 2025 | 19.5% | +6.2 |
| Q2 FY2025 | Jun 30, 2025 | 12.5% | −14.3 |
| Q1 FY2025 | Mar 31, 2025 | 9.4% | −6.2 |
| Q4 FY2024 | Dec 31, 2024 | 11.9% | −5.9 |
| Q3 FY2024 | Sep 30, 2024 | 13.3% | −0.3 |
| Q2 FY2024 | Jun 30, 2024 | 26.9% | +13.6 |
| Q1 FY2024 | Mar 31, 2024 | 15.6% | +16.1 |
| Q4 FY2023 | Dec 31, 2023 | 17.8% | +2.6 |
| Q3 FY2023 | Sep 30, 2023 | 13.6% | +24.1 |
| Q2 FY2023 | Jun 30, 2023 | 13.3% | +27.7 |
| Q1 FY2023 | Mar 31, 2023 | -0.5% | +15.3 |
| Q4 FY2022 | Dec 31, 2022 | 15.2% | +12.7 |
| Q3 FY2022 | Sep 30, 2022 | -10.5% | −8.8 |
| Q2 FY2022 | Jun 30, 2022 | -14.4% | −13.8 |
| Q1 FY2022 | Mar 31, 2022 | -15.8% | −4.4 |
| Q4 FY2021 | Dec 31, 2021 | 2.5% | +26.0 |
| Q3 FY2021 | Sep 30, 2021 | -1.7% | +13.4 |
| Q2 FY2021 | Jun 30, 2021 | -0.6% | +10.3 |
| Q1 FY2021 | Mar 31, 2021 | -11.4% | +10.8 |
| Q4 FY2020 | Dec 31, 2020 | -23.5% | −17.1 |
| Q3 FY2020 | Sep 30, 2020 | -15.1% | −31.1 |
| Q2 FY2020 | Jun 30, 2020 | -10.9% | +14.4 |
| Q1 FY2020 | Mar 31, 2020 | -22.3% | −2.1 |
| Q4 FY2019 | Dec 31, 2019 | -6.4% | +3.3 |
| Q3 FY2019 | Sep 30, 2019 | 16.0% | +15.5 |
| Q2 FY2019 | Jun 30, 2019 | -25.3% | −27.1 |
| Q1 FY2019 | Mar 31, 2019 | -20.2% | −23.7 |
| Q4 FY2018 | Dec 31, 2018 | -9.7% | −37.0 |
| Q3 FY2018 | Sep 30, 2018 | 0.4% | −10.1 |
| Q2 FY2018 | Jun 30, 2018 | 1.8% | −7.2 |
| Q1 FY2018 | Mar 31, 2018 | 3.5% | −5.5 |
| Q4 FY2017 | Dec 31, 2017 | 27.3% | +40.0 |
| Q3 FY2017 | Sep 30, 2017 | 10.5% | – |
| Q2 FY2017 | Jun 30, 2017 | 9.0% | – |
| Q1 FY2017 | Mar 31, 2017 | 9.0% | – |
| Q4 FY2016 | Dec 31, 2016 | -12.7% | – |
See a number that looks wrong?